A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine
Clinical trial NCT03718468 · COMPLETED
Trial details
- NCT number
- NCT03718468
- Sponsor
- Medigen Vaccine Biologics Corp.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2019-07-03
- Enrollment
- 842
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.